ThromboRisk ThromboRisk Genetic study of thrombotic risk Genetic testing for the assessment of venous thromboembolism risk. This panel includes the study of genes related to conventional coagulation pathways, as well as other genes involved in the risk of thrombosis. Hereditary thrombophilia is directly associated with recurrent pregnancy lossand other obstetric complications. The test facilitates the estimation of thrombotic risk, which allows the specialist to assess the need for antithrombotic treatment or other prophylactic measures. Veritas offers two analysis options: ThromboRisk basic Analyzes the 3 genetic variants that contribute significantly to the risk of thrombosis in the F5, F2, and F12 genes. ThromboRisk Analyzes the 3 genetic variants with high risk (F5, F2, F12), and 21 variants with moderate risk in 18 genes and in intronic regions, allowing an individualized thrombotic risk score to be determined for better risk assessment. Who is it recommended for? Women with a history of recurrent miscarriages. Patients who are starting or receiving treatment with oral contraceptives, hormone replacement therapy, or fertility cycles. People with a family history of venous thrombosis or a personal history of thromboembolic disease. Are you interested in ThromboRisk but you do not have a doctor that provides the service? Our medical professionals can help you Contact usWhy choose ThromboRisk? It includes genes from both conventional and alternative pathways to identify patients at high and moderate risk of reproductive complications. The ThromboRisk basic option provides essential information related to the most common high-risk variants. The ThromboRisk option provides a complete report with a description of the variants found, as well as the overall thrombosis risk factor based on the variants detected.Hereditary thrombophilia is responsible for more than 50% of thrombosis cases.Are you interested in offering ThromboRisk from Veritas?Contact us and find out how we can work together.Contact us
